CATALOGO DEI PRODOTTI DELLA RICERCA

GIACOPUZZI, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.906
EU - Europa 5.692
AS - Asia 4.178
SA - Sud America 587
AF - Africa 205
Continente sconosciuto - Info sul continente non disponibili 190
OC - Oceania 17
Totale 16.775
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.759
RU - Federazione Russa 2.485
SG - Singapore 1.673
CN - Cina 1.140
GB - Regno Unito 979
IT - Italia 777
BR - Brasile 461
VN - Vietnam 408
HK - Hong Kong 311
DE - Germania 265
SE - Svezia 256
IE - Irlanda 254
FR - Francia 215
FI - Finlandia 164
KR - Corea 148
BD - Bangladesh 124
CA - Canada 75
JP - Giappone 65
IN - India 64
UA - Ucraina 58
TR - Turchia 57
NL - Olanda 45
ES - Italia 44
AR - Argentina 42
NG - Nigeria 39
ZA - Sudafrica 36
TG - Togo 33
ID - Indonesia 30
AT - Austria 28
MX - Messico 28
BJ - Benin 27
IQ - Iraq 26
PL - Polonia 23
CO - Colombia 21
AU - Australia 17
LT - Lituania 17
UZ - Uzbekistan 16
IL - Israele 15
CL - Cile 13
EC - Ecuador 13
MA - Marocco 13
AE - Emirati Arabi Uniti 12
PK - Pakistan 12
BE - Belgio 11
PY - Paraguay 11
GR - Grecia 10
NO - Norvegia 10
VE - Venezuela 10
CR - Costa Rica 9
DZ - Algeria 9
EG - Egitto 9
IR - Iran 9
KE - Kenya 9
SA - Arabia Saudita 9
SC - Seychelles 9
CZ - Repubblica Ceca 8
PE - Perù 7
PH - Filippine 7
AL - Albania 6
JM - Giamaica 6
JO - Giordania 6
KZ - Kazakistan 6
MY - Malesia 6
PT - Portogallo 6
UY - Uruguay 6
EU - Europa 5
LB - Libano 5
SI - Slovenia 5
AO - Angola 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
LV - Lettonia 4
NI - Nicaragua 4
OM - Oman 4
PA - Panama 4
BB - Barbados 3
CI - Costa d'Avorio 3
LK - Sri Lanka 3
NP - Nepal 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
UG - Uganda 2
AM - Armenia 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
Totale 16.574
Salva come PNG Salva come JPEG
Città #
Singapore 891
Ashburn 816
Moscow 804
Southend 796
San Jose 622
Dallas 504
Chandler 486
Hong Kong 302
Verona 293
Jacksonville 264
Dublin 254
Council Bluffs 229
New York 225
Beijing 219
The Dalles 190
Woodbridge 184
Ho Chi Minh City 147
Los Angeles 135
Ann Arbor 123
Hanoi 87
Jinan 76
Lawrence 73
Princeton 73
Munich 70
Wilmington 70
Helsinki 64
Milan 64
Redmond 57
Tokyo 57
Houston 56
Nanjing 55
Santa Clara 53
São Paulo 50
Buffalo 49
Shenyang 46
London 45
Hebei 40
Seoul 39
Abuja 38
Rome 37
Atlanta 36
Orem 36
Redondo Beach 35
Lomé 33
Changsha 32
Columbus 31
Sindelfingen 30
Tianjin 29
Zhengzhou 29
Guangzhou 28
Seattle 28
Amsterdam 27
Brooklyn 27
Cotonou 27
Frankfurt am Main 27
Dong Ket 24
Denver 23
Haikou 22
San Francisco 22
Johannesburg 21
Madrid 21
Montreal 21
Chennai 20
Hangzhou 20
Nanchang 19
Turku 19
Vienna 19
Warsaw 19
Ankara 18
Chicago 18
Lappeenranta 18
Phoenix 18
Toronto 18
Washington 18
Manchester 17
Stockholm 17
Jiaxing 16
Taizhou 16
Ningbo 15
Nuremberg 14
Poplar 14
Rio de Janeiro 14
Shanghai 14
Taiyuan 14
Tombolo 14
Baghdad 13
Belo Horizonte 13
Boston 13
Jakarta 13
Redwood City 13
Tashkent 13
Boardman 12
Da Nang 12
Mumbai 12
Naples 12
Bologna 11
Brussels 11
Biên Hòa 10
Dongguan 10
Paris 10
Totale 9.859
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 319
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 298
[Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. 269
Pediatric Palliative Care: Historical Origins and a Glimpse into Ethical Issues 251
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study 225
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 212
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 209
Adenocarcinoma of the esophagogastric junction 209
Outcomes after Surgical Treatment of Oesophagogastric Cancer with Synchronous Liver Metastases: A Multicentre Retrospective Cohort Study 208
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 205
ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer 202
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 201
Thoracic Aortic Pseudoaneurysm after Esophageal Perforation and Mediastinitis Caused by Accidental Ingestion of a Mutton Bone: A Case Report on Staged Endoscopic and Endovascular Treatments 198
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 189
Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us? 188
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event 185
Changing clinical and pathological features of gastric cancer over time. 184
Acute bleeding obstruction pancreatitis after Roux-en-Y anastomosis in total gastrectomy: a single center experience 183
Textbook outcome following oesophagectomy for cancer: international cohort study 182
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 180
Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci 178
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 176
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 174
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 171
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 170
Effectiveness of endoscopic vacuum therapy as rescue treatment in refractory leaks after gastro-esophageal surgery 169
Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. 168
Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center. 165
Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer 164
Feasibility and safety of an enhanced recovery protocol (ERP) for upper GI surgery in elderly patients (≥ 75 years) in a high-volume surgical center 161
Gastric conduit perforation after Ivor Lewis esophagectomy successfully treated with endoscopic vacuum therapy (E-VAC): a case report 161
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 159
Complications after gastrectomy for cancer: Italian perspective 158
Western strategy for EGJ carcinoma 155
Adenocarcinoma of the esophagogastric junction; going up or down? 154
Active surveillance for clinical complete responders after chemoradiotherapy for oesophageal squamous cell carcinoma 153
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. 153
Tailored treatment for signet ring cell gastric cancer 153
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 152
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 152
Effect of Pyloroplasty on Gastric Conduit Emptying and Patients' Quality of Life After Ivor Lewis Esophagectomy 152
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 151
Lymphadenectomy: how to do it? 151
Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer 151
Surgical treatment of gastric cancer with coexistent abdominal aortic aneurysm. Personal experience and literature review 150
Proximal Gastrectomy: Technical Notes 150
Preliminary Experience with Prophylactic Thoracic Endovascular Aortic Repair in Patients Affected by Advanced Esophageal Cancer 149
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer 148
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 148
Comparison of outcomes of multiple platforms for assisted robotic-prostatectomy: rationale and design 148
Utility of Abdominal Drain in Gastrectomy (ADiGe) Trial: study protocol for a multicenter non-inferiority randomized trial 147
Lymph node involvement in advanced gastroesophageal junction adenocarcinoma 146
Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? 145
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 144
Comparison of short-term outcomes from the International Oesophago-Gastric Anastomosis Audit (OGAA), the Esophagectomy Complications Consensus Group (ECCG), and the Dutch Upper Gastrointestinal Cancer Audit (DUCA) 143
Robotic versus open Ivor-Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate 142
Esophageal surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it 141
Nodal Staging in Adenocarcinoma of the Gastro-Esophageal Junction. Proposal of a Specific Staging System. Ann Surg Oncol. 140
Super-extended (D3) lymphadenectomy in advanced gastric cancer . 139
L’ espressione di BIRC3 come predittore di resistenza alla chemioradioterapia neoadiuvante nell’adenocarcinoma del cardias e nel carcinoma squamoso dell’esofago 138
Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience 138
Laparoscopic transhiatal suture and gastric valve as a safe and feasible treatment for Boerhaave's syndrome: an Italian single center case series study 138
Clinical predictors of postoperative complications in the context of enhanced recovery (ERAS) in patients with esophageal and gastric cancer 137
Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre 135
International consensus on a complications list after gastrectomy for cancer 135
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience 133
Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery 131
Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study 128
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 128
Severe necrotic and septic pancreatitis. Indications to endoscopic surgical and nutritional therapy 126
Robotic-assisted surgical staging with sentinel node biopsy for apparently early-stage endometrial cancer using the modular multi-arm surgical robot system Versius® (Cambridge Medical Robots): a case series 124
Indexes of surgical quality in gastric cancer surgery: experience of an Italian network 124
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer 124
Treatment of esophago-gastric junction adenocarcinoma 124
The "Weekday Effect" on Enhanced Recovery after Surgery Protocol for Gastrectomy 122
Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. 122
External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study 122
Incidence and Grading of Complications After Gastrectomy for Cancer Using the GASTRODATA Registry: A European Retrospective Observational Study 122
Long term results of ajuvant treatment in epidermoid carcinoma of the thoracic esophagus 121
Prosthetic voice rehabilitation after laryngoesophagectomy: surgical and functional outcomes 117
Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution 116
Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal. 112
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series 112
Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 112
Is a robot surgeon with AI the ideal surgeon? A philosophical analysis 111
Long-Term Results with Surgery Alone and Multimodal Treatments 111
Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer: Insights From the GastroBenchmark and GASTRODATA databases 110
Major vessel resection for complete cytoreduction in primary advanced and recurrent ovarian malignancies: A case series and systematic review of the literature - pushing the boundaries in oncovascular surgery 110
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 109
Clinical outcomes of patients with complicated post-operative course after gastrectomy for cancer: a GIRCG study using the GASTRODATA registry 108
MULTICENTER STUDY ON THE INCIDENCE AND TREATMENT OF MEDIASTINAL LEAKS AFTER ESOPHAGECTOMY (MUMELE 2) 107
Risultati preliminari del trattamento neoadiuvante dell’adenocarcinoma del giunto esofago-gastrico. 107
Transthoracic esophagectomy compared to transhiatal extended gastrectomy for adenocarcinoma of the esophagogastric junction: a multicenter retrospective cohort study 104
Cutoff values of major surgical complications rates after gastrectomy 103
Impact of COVID-19 outbreak on esophageal cancer surgery in Northern Italy: lessons learned from a multicentric snapshot 101
Management, short and long-term outcomes in septegenerians and octegenerians undergoing gastrectomy for cancer 100
Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population-on behalf of the Italian Research Group for Gastric Cancer 100
Does Pathological Stage and Nodal Involvement Influence Long Term Oncological Outcomes after CROSS Regimen for Adenocarcinoma of the Esophagogastric Junction? A Multicenter Retrospective Analysis 100
Follow-up after gastrectomy for cancer. An appraisal of the Italian Research Group for Gastric Cancer 96
Perioperative Outcomes in Open Versus Minimally Invasive Gastrectomy For Gastric Cancer: A European Multicenter Study Based on the GASTRODATA Registry 91
Totale 15.137
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.972
article - articoli 58.853
book - libri 579
conference - conferenze 500
curatela - curatele 0
other - altro 440
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.600
Totale 123.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022365 0 0 1 48 27 25 8 40 15 20 31 150
2022/20231.461 82 152 133 217 115 373 5 105 179 17 32 51
2023/20241.025 25 70 75 112 90 205 48 61 24 69 190 56
2024/20252.677 123 143 142 418 145 154 203 132 343 216 200 458
2025/20268.078 494 381 490 1.394 2.118 537 758 450 579 457 219 201
2026/2027423 119 275 29 0 0 0 0 0 0 0 0 0
Totale 16.775